Content about Clostridium difficile

May 8, 2012

Study: Probiotics may be able to reduce antibiotic-associated diarrhea incidence

Consumption of probiotics is associated with a reduced risk of antibiotic-associated diarrhea, a common adverse effect of antibiotic use, according to a review and meta-analysis of previous studies published in the May 9 issue of JAMA, the Journal of the American Medical Association.

April 11, 2012

Prasco to market authorized generic Vancocin

Prasco Labs will market an authorized generic version of a drug used to treat diarrhea caused by a bacterial infection, the company said Wednesday.

April 10, 2012

FDA approves Watson diarrhea drug

The Food and Drug Administration has approved a generic version of a drug for diarrhea made by Watson, the company said Tuesday.

February 9, 2012

FDA issues warning on PPI, H2 blocker antacids: May increase risk of CDAD

The Food and Drug Administration on Wednesday issued a public warning that the use of proton-pump inhibitors or H2 blockers may be associated with an increased risk of Clostridium difficile–associated diarrhea, or CDAD.

December 16, 2011

FDA approves new labeling for ViroPharma's Vancocin

ViroPharma has received approval for updated labeling to its antibiotic drug.

May 31, 2011

Dificid gets nod as CDAD treatment

The Food and Drug Administration has approved a treatment for diarrhea caused by a bacterial infection.

January 24, 2011

FDA accepts filing for CDI treatment

The Food and Drug Administration has accepted a regulatory filing from Optimer Pharmaceuticals for a drug to treat bacterial infections.

November 8, 2010

FDA grants fast-track designation for CDI vaccine

A vaccine for a bacterial infection that affects the gastrointestinal tract has been granted expedited...